Healthcare Innovation CSR News

Alkermes Shares Immuno Oncology Clinical Trial Research

Multimedia with summary

We are pleased to share clinical trial data on our investigational #immunooncology therapy and are excited to be a part of the 17th EADO Congress and 2021 World Mobile Congress Interactive Virtual Meeting. https://worldmelanoma2021.com/

Smarter Technology Is Turning Deadly Venom Into Potential Medicine

Blog

Dr. Zoltan Takacs uses a ThinkPad to analyze some of the world's deadliest toxins and turn them into medicine leads.

Most people avoid venomous creatures. Dr. Zoltan Takacs has spent his life chasing them.

The renowned scientist and explorer seeks out the venoms of some of the world’s deadliest creatures — snakes, spiders, scorpions and more — with the hope that their lethal toxins will provide a template for designing new medicines. The basic logic behind his method: What can kill you just might save your life.

Over-the-Counter Rapid COVID-19 Testing, in Your Hands

BinaxNOW Ag is now available over-the-counter, bringing accessible COVID-19 rapid self-testing to the masses.
Blog

Through the course of the COVID-19 pandemic, we've needed answers.

We've filed into long lines, ventured to doctors' offices and urgent care clinics, waited days for results or for home tests to arrive by mail, and postponed gatherings, celebrations and holidays.

Now, those much-needed answers will be in your hands.

Enter: our BinaxNOW COVID-19 Self Test

How the Edge Is Reshaping Healthcare

Edge computing and AI promise to make healthcare delivery cheaper, easier, and better for everyone. It couldn't happen at a better time.
Blog

By Dan Tynan

More in Store for Connected Diabetes Care

Managing diabetes with FreeStyle Libre tech will be easier with partners for insulin delivery, online coaching.
Blog

As we have continued to expand the FreeStyle franchise of diabetes care systems — from testing strips to the first generation FreeStyle Libre continuous glucose monitor (CGM) to the FreeStyle Libre 2 integrated system and our latest next-gen FreeStyle Libre 3, approved for use in Europe — we are also working to expand offerings from leadi

Equitable Access To Healthcare Starts With Affordable Broadband For All

By Mike Katz | Brand Contributor
Article

Even in the best of times, America has had a troubled relationship with equitable healthcare.

Qualcomm Wireless Reach: Wireless-enabled Video Solutions for Tuberculosis Treatment

Mobile video content enhances remote training and counseling for TB management
Article

Tuberculosis (TB) has been treatable for the past 60 years, yet remains a leading cause of death worldwide.1 In 2018 alone, 10 million people fell ill with TB, and 1.5 million people died from the disease.2 Many countries have run TB control programs for decades and achieved good results, but global eradication is distant. The TB treatment regimen prescribed by the World Health Organization is painful and lengthy, requiring at least six months of adherence. Getting patients to adhere to this regimen is a challenge.

Abbott's BinaxNOW™ Rapid Antigen Self Test Receives FDA Emergency Use Authorization for Asymptomatic, Over-the-Counter, Non-Prescription, Multi-Test Use

Summary: 
  • FDA Emergency Use Authorization permits asymptomatic, non-prescription, over-the-counter self use for people with or without symptoms
  • The BinaxNOW COVID-19 Self Test is identical to the professional-use test, used since August 2020, bringing the most studied and widely used rapid antigen test to retail shelves across the country
  • BinaxNOW Self Test will be available nationwide and in large quantities at major food, drug and mass merchandiser retailers nationally and will be priced affordably, similar to common over-the-counter (OTC) tests
  • Together with vaccines, serial testing of asymptomatic people will help restore a sense of safety in everyday settings where people gather
  • Asymptomatic multi-test authorization also applies to BinaxNOW professional-use test

 

Press Release
  • FDA Emergency Use Authorization permits asymptomatic, non-prescription, over-the-counter self use for people with or without symptoms
  • The BinaxNOW COVID-19 Self Test is identical to the professional-use test, used since August 2020, bringing the most studied and widely used rapid antigen test to retail shelves across the country
  • BinaxNOW Self Test will be available nationwide and in large quantities at major food, drug and mass merchandiser retailers nationally and will be priced affordably, similar to common over-the-counter (OTC) tests
  • Together with vaccines, serial testing of asymptomatic people will help restore a sense of safety in everyday settings where people gather
  • Asymptomatic multi-test authorization also applies to BinaxNOW professional-use test

 

How Do We Help Prevent the Next Pandemic? Collaboration.

Our Pandemic Defense Coalition is here to help stop future pandemics in their tracks through global partnership.
Blog

We think it's safe to say, nobody ever wants to endure another pandemic. COVID-19 emphasized the importance of preparedness and containing viral threats before they reach every corner of the world.

Pages

Subscribe to Healthcare Innovation